Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

BACKGROUND: Treatment of severe diffuse congenital hyperinsulinism (CHI) without sufficient response to diazoxide is complicated by the lack of approved drugs. Therefore, patients are often hospitalized long-term or have to undergo pancreatic surgery if episodes of severe hypoglycaemia cannot be pre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Orphanet J Rare Dis
Hlavní autoři: Corda, Heike, Kummer, Sebastian, Welters, Alena, Teig, Norbert, Klee, Dirk, Mayatepek, Ertan, Meissner, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455078/
https://ncbi.nlm.nih.gov/pubmed/28576129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0653-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky